Frontiers in Endocrinology (Mar 2024)

Effect of maternal serum albumin level on birthweight and gestational age: an analysis of 39200 singleton newborns

  • Jiayi Wu,
  • Jiayi Wu,
  • Jiayi Wu,
  • Xiaorui Liu,
  • Xiaorui Liu,
  • Xiaorui Liu,
  • Chuanmei Qin,
  • Chuanmei Qin,
  • Chuanmei Qin,
  • Jinwen Zhang,
  • Jinwen Zhang,
  • Jinwen Zhang,
  • Xueqing Liu,
  • Xueqing Liu,
  • Xueqing Liu,
  • Jianing Hu,
  • Jianing Hu,
  • Jianing Hu,
  • Fan Wu,
  • Fan Wu,
  • Fan Wu,
  • Cailian Chen,
  • Cailian Chen,
  • Yi Lin,
  • Yi Lin,
  • Yi Lin,
  • Yi Lin

DOI
https://doi.org/10.3389/fendo.2024.1266669
Journal volume & issue
Vol. 15

Abstract

Read online

BackgroundSerum albumin plays a pivotal role in regulating plasma oncotic pressure and modulating fluid distribution among various body compartments. Previous research examining the association between maternal serum albumin levels and fetal growth yielded limited and inconclusive findings. Therefore, the specific influence of serum albumin on fetal growth remains poorly understood and warrants further investigation.MethodsA retrospective study involved 39200 women who had a singleton live birth at a tertiary-care academic medical center during the period from January 2017 to December 2020. Women were categorized into four groups according to the quartile of albumin concentration during early pregnancy: Q1 group, ≤41.0 g/L; Q2 group, 41.1-42.6 g/L; Q3 group, 42.7-44.3 g/L and Q4 group, >44.3 g/L. The main outcome measures were mid-term estimated fetal weight, birthweight and gestational age. Multivariate linear and logistic regression analysis were performed to detect the independent effect of maternal serum albumin level on fetal growth after adjusting for important confounding variables.ResultsIn the crude analysis, a significant inverse correlation was found between early pregnancy maternal serum albumin levels and fetal growth status, including mid-term ultrasound measurements, mid-term estimated fetal weight, birthweight, and gestational age. After adjustment for a number of confounding factors, mid-term estimated fetal weight, birthweight, and birth height decreased significantly with increasing albumin levels. Compared to the Q2 group, the Q4 group had higher rates of preterm birth (aOR, 1.16; 95% CI, 1.01–1.34), small-for-gestational-age (aOR, 1.27; 95% CI, 1.11–1.45) and low birthweight (aOR, 1.41; 95% CI, 1.18–1.69), and lower rate of large-for-gestational-age (aOR, 0.85; 95% CI, 0.78–0.94). Moreover, to achieve the optimal neonatal outcome, women with higher early pregnancy albumin levels required a greater reduction in albumin levels in later pregnancy stages.ConclusionsA higher maternal serum albumin level during early pregnancy was associated with poor fetal growth, with the detrimental effects becoming apparent as early as the mid-gestation period. These findings provided vital information for clinicians to predict fetal growth status and identify cases with a high risk of adverse neonatal outcomes early on.

Keywords